The store will not work correctly when cookies are disabled.
(S)-N-butyl-5-oxopyrrolidine-2-carboxamide
ID: ALA4246026
PubChem CID: 15486634
Max Phase: Preclinical
Molecular Formula: C9H16N2O2
Molecular Weight: 184.24
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCNC(=O)[C@@H]1CCC(=O)N1
Standard InChI: InChI=1S/C9H16N2O2/c1-2-3-6-10-9(13)7-4-5-8(12)11-7/h7H,2-6H2,1H3,(H,10,13)(H,11,12)/t7-/m0/s1
Standard InChI Key: UICDNADSGVMHKL-ZETCQYMHSA-N
Molfile:
RDKit 2D
13 13 0 0 0 0 0 0 0 0999 V2000
11.1641 -2.4888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9854 -2.4888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2398 -1.7079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5768 -1.2258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9140 -1.7079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1325 -1.4557 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9471 -1.2918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6633 -1.6928 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9384 -0.4787 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6720 -2.5141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9646 -2.9344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9734 -3.7556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2660 -4.1718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
5 6 2 0
3 7 1 6
7 8 1 0
7 9 2 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 184.24 | Molecular Weight (Monoisotopic): 184.1212 | AlogP: 0.18 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.76 | CX Basic pKa: ┄ | CX LogP: -0.15 | CX LogD: -0.15 |
Aromatic Rings: ┄ | Heavy Atoms: 13 | QED Weighted: 0.61 | Np Likeness Score: -0.58 |
References
1. Gang FL, Zhu F, Li XT, Wei JL, Wu WJ, Zhang JW.. (2018) Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead., 26 (16): [PMID:30119995] [10.1016/j.bmc.2018.07.041] |